why choose us

First received: June 03, 2023

Clinical Trial: BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Bronchiolitis Obliterans Syndrome

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation

Brief Summary: The goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT) recipients who have been newly diagnosed or have developing (early stage) bronchiolitis obliterans syndrome (BOS).The name of the study drugs involved in this study are:Belumosudil (an immunotherapy)Fluticasone (an intranasal corticosteroid)Azithromycin (an antibiotic)Montelukast (a leukotriene receptor antagonist)Prednisone (a corticosteroid)

Read more